Vor Biopharma Inc.

Ownership Transactions Reported by 16 Insiders

Symbol
VOR on Nasdaq
Location
100 Cambridgepark Drive, Suite 101, Cambridge, MA

Insiders trading volume in the past year

Vor Biopharma Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
5AM Ventures VI, L.P. 10%+ Owner $3.22M Nov 16, 2021
Robert Ang PRESIDENT AND CEO, Director $677K Nov 6, 2024
Nathan D. Jorgensen Chief Financial Officer $331K May 6, 2024
Tirtha Chakraborty Chief Scientific Officer $146K Nov 6, 2024
Eyal C. Attar Chief Medical Officer $78.9K -$20.4K -20.5% Nov 6, 2024
Amy Quinlan Vice President of Finance $43.3K Nov 6, 2024
Daniella Beckman Director May 23, 2024
Christopher Slapak Chief Medical Officer Feb 1, 2022
Matthew R. Patterson Director May 23, 2024
Fouad Namouni Director May 23, 2024
Joshua Resnick Director May 23, 2024
Han Wook Choi Chief Financial Officer Sep 30, 2024
David Lubner Director May 23, 2024
Sven Ante Lundberg Director May 23, 2024
Kush Parmar Director, 10%+ Owner Jun 14, 2022
Ra Capital Management, L.P. Director, 10%+ Owner May 23, 2024

Recent Insider Transactions by Companies or Individuals for Vor Biopharma Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.